We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
126
Honeywell
HON
$77.1B
$12.6M 0.22%
91,263
+8,247
+10% +$1.11M
TIF
127
DELISTED
Tiffany & Co.
TIF
$12.6M 0.22%
121,201
+14,560
+14% +$1.39M
FITB
128
Fifth Third Bancorp
FITB
$52B
$12.3M 0.21%
405,592
-47,121
-10% -$1.37M
WHR icon
129
Whirlpool
WHR
$2.42B
$12.3M 0.21%
72,715
+17,149
+31% +$2.91M
ZBH icon
130
Zimmer Biomet
ZBH
$17.7B
$12.2M 0.21%
104,458
+9,625
+10% +$1.09M
PH icon
131
Parker-Hannifin
PH
$125B
$12.2M 0.21%
61,008
-34,748
-36% -$6.46M
ADI icon
132
Analog Devices
ADI
$181B
$12.1M 0.21%
136,258
-192,157
-59% -$17M
ALNY icon
133
Alnylam Pharmaceuticals
ALNY
$36.3B
$12.1M 0.21%
95,108
-24,892
-21% -$3.13M
CLVS
134
DELISTED
Clovis Oncology, Inc.
CLVS
$11.9M 0.21%
174,500
-43,000
-20% -$3.01M
BDX icon
135
Becton Dickinson
BDX
$43.1B
$11.8M 0.2%
56,631
-302
-0.5% -$63.2K
RF icon
136
Regions Financial
RF
$26.3B
$11.8M 0.2%
680,513
-11,831
-2% -$189K
CVX icon
137
Chevron
CVX
$388B
$11.6M 0.2%
92,296
-55,950
-38% -$6.63M
IBM icon
138
IBM
IBM
$202B
$11.5M 0.2%
78,686
+840
+1% +$122K
MON
139
DELISTED
Monsanto Co
MON
$11.5M 0.2%
98,561
+4,216
+4% +$502K
SJR
140
DELISTED
Shaw Communications Inc.
SJR
$11.5M 0.2%
502,465
+180,306
+56% +$4.06M
NKE icon
141
Nike
NKE
$61.9B
$11.3M 0.2%
180,503
-17,008
-9% -$978K
AEP icon
142
American Electric Power
AEP
$73.7B
$11.1M 0.19%
151,252
+1,312
+0.9% +$98K
XYL icon
143
Xylem
XYL
$28.5B
$11M 0.19%
161,892
+3,493
+2% +$232K
KMI icon
144
Kinder Morgan
KMI
$73.1B
$11M 0.19%
607,688
+262,718
+76% +$4.71M
WDC icon
145
Western Digital
WDC
$179B
$11M 0.19%
182,259
-1,663
-0.9% -$107K
STT icon
146
State Street
STT
$50.9B
$10.9M 0.19%
112,166
+34,997
+45% +$3.35M
KGC icon
147
Kinross Gold
KGC
$28.5B
$10.8M 0.19%
2,501,985
-648,293
-21% -$2.7M
OMC icon
148
Omnicom Group
OMC
$22.7B
$10.8M 0.19%
148,353
+118,593
+398% +$8.51M
ZION icon
149
Zions Bancorporation
ZION
$10.1B
$10.8M 0.19%
211,490
-132,249
-38% -$6.33M
ELV icon
150
Elevance Health
ELV
$81.9B
$10.5M 0.18%
46,671
-14,365
-24% -$3.06M
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.